These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 20455765)

  • 1. Alcohol use accelerates HIV disease progression.
    Baum MK; Rafie C; Lai S; Sales S; Page JB; Campa A
    AIDS Res Hum Retroviruses; 2010 May; 26(5):511-8. PubMed ID: 20455765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.
    Baum MK; Rafie C; Lai S; Sales S; Page B; Campa A
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):93-9. PubMed ID: 19295339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil.
    Teixeira C; Dourado Mde L; Santos MP; Brites C
    AIDS Res Hum Retroviruses; 2013 May; 29(5):799-804. PubMed ID: 23294471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine reduces thymic endocrine function: another mechanism for accelerated HIV disease progression.
    Rafie C; Campa A; Smith S; Huffman F; Newman F; Baum MK
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):815-22. PubMed ID: 21142650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of history of injection drug use and alcoholism on HIV disease progression.
    Lima VD; Kerr T; Wood E; Kozai T; Salters KA; Hogg RS; Montaner JS
    AIDS Care; 2014 Jan; 26(1):123-9. PubMed ID: 23767757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol Use and HIV Disease Progression in an Antiretroviral Naive Cohort.
    Hahn JA; Cheng DM; Emenyonu NI; Lloyd-Travaglini C; Fatch R; Shade SB; Ngabirano C; Adong J; Bryant K; Muyindike WR; Samet JH
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):492-501. PubMed ID: 29303844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and Indirect Effects of Heavy Alcohol Use on Clinical Outcomes in a Longitudinal Study of HIV Patients on ART.
    Kahler CW; Liu T; Cioe PA; Bryant V; Pinkston MM; Kojic EM; Onen N; Baker JV; Hammer J; Brooks JT; Patel P
    AIDS Behav; 2017 Jul; 21(7):1825-1835. PubMed ID: 27392417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.
    Lucas GM; Gebo KA; Chaisson RE; Moore RD
    AIDS; 2002 Mar; 16(5):767-74. PubMed ID: 11964533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
    Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
    BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    Liang J; Nosova E; Reddon H; Nolan S; Socías E; Barrios R; Milloy MJ
    AIDS; 2020 Jul; 34(9):1389-1396. PubMed ID: 32590435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol use and viral suppression in HIV-positive Kenyan female sex workers on antiretroviral therapy.
    Long JE; Richardson BA; Wanje G; Wilson KS; Shafi J; Mandaliya K; Simoni JM; Kinuthia J; Jaoko W; McClelland RS
    PLoS One; 2020; 15(11):e0242817. PubMed ID: 33232378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hazardous alcohol consumption is not associated with CD4+ T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study.
    Wandera B; Tumwesigye NM; Nankabirwa JI; Kambugu AD; Mafigiri DK; Kapiga S; Sethi AK
    PLoS One; 2017; 12(6):e0180015. PubMed ID: 28665974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adults.
    Kalichman SC; Grebler T; Amaral CM; McNerney M; White D; Kalichman MO; Cherry C; Eaton L
    Int J Behav Med; 2014; 21(5):811-20. PubMed ID: 24085706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
    Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
    HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction.
    Towner WJ; Xu L; Leyden WA; Horberg MA; Chao CR; Tang B; Klein DB; Hurley LB; Quesenberry CP; Silverberg MJ
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):321-7. PubMed ID: 22343179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
    Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ;
    JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.